Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merck & Co
(NY:
MRK
)
80.93
-1.46 (-1.77%)
Official Closing Price
Updated: 5:00 PM EDT, Jul 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Merck & Co
< Previous
1
2
3
4
5
6
7
8
9
...
87
88
Next >
“We’re In A Stock Pickers Market”
March 22, 2025
Markets have been oscillating up and down for weeks, creating what resembles a sine wave pattern. As the analyst notes,
Via
Talk Markets
Topics
ETFs
Which Is The Healthiest Investment: Merck Or Pfizer
March 21, 2025
Adeep dive into Merck and Pfizer, two of the biggest pharmaceutical companies out there.
Via
Talk Markets
Topics
Stocks / Equities
Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
March 21, 2025
UK pharma leaders warn excessive NHS levies threaten industry growth, urging the government to reform payments. The ABPI highlights declining UK R&D investment and falling global competitiveness.
Via
Benzinga
Merck & Co's Options: A Look at What the Big Money is Thinking
March 18, 2025
Via
Benzinga
Merck & Co Unusual Options Activity For March 10
March 10, 2025
Via
Benzinga
Spotlight on Merck & Co: Analyzing the Surge in Options Activity
March 04, 2025
Via
Benzinga
Decoding Merck & Co's Options Activity: What's the Big Picture?
February 27, 2025
Via
Benzinga
Pliant Therapeutics' Investigational Cancer Drug Shows Antitumor Activity Across Multiple Tumor Types
March 17, 2025
Pliant Therapeutics' PLN-101095 showed partial responses in ICI-refractory tumors, with a 50% ORR at the highest dose tested in its Phase 1 trial.
Via
Benzinga
Why MERCK & CO. INC. (NYSE:MRK) qualifies as a good dividend investing stock.
March 17, 2025
Balancing Dividends and Fundamentals: The Case of MERCK & CO. INC. (NYSE:MRK).
Via
Chartmill
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
March 16, 2025
Via
The Motley Fool
Topics
Stocks
A Closer Look at Merck & Co's Options Market Dynamics
March 14, 2025
Via
Benzinga
These S&P500 stocks are gapping in today's session
March 14, 2025
Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Friday and stay ahead of the market trends.
Via
Chartmill
Inflation Isn’t Going Away, But These Sectors Don’t Care
March 13, 2025
The CPI and PPI releases this week came in more or less at estimates - nothing to alarm the talking heads, anyway. They show inflation slowing down but not receding.
Via
Talk Markets
Topics
ETFs
Economy
Stocks / Equities
How Do Investors Really Feel About Merck & Co?
March 12, 2025
Via
Benzinga
Merck Plans Regulatory Submission For Two-Drug Regime For HIV Infection By Mid-2025
March 12, 2025
Merck's DOR/ISL met primary efficacy and safety goals in two Phase 3 HIV trials. Marketing applications are planned for mid-2025.
Via
Benzinga
Merck Injects $1 Billion To Expand Vaccine Production In US
March 11, 2025
Merck unveils a $1 billion vaccine manufacturing facility in Durham, North Carolina, expanding its U.S. production and research investments.
Via
Benzinga
Moderna: 4 Key Reasons the CEO Just Bought $5M in Shares
March 11, 2025
Moderna stock has fallen to levels not seen in 5 years, but the CEO just spent $5 million buying stock in the open market underscoring his optimism for gains.
Via
MarketBeat
Institutional Investors Bet $1B on These 4 Stocks—Should You?
March 09, 2025
Institutional investors snapped up at least $1 billion in shares of each of these four companies in Q4 of 2024 - should you buy as well?
Via
MarketBeat
3 Magnificent S&P 500 Dividend Stocks Down 20% to 63% to Buy and Hold Forever
March 09, 2025
Great investments are even better and more fruitful when you can buy them at a discount.
Via
The Motley Fool
Topics
Stocks
5 Top Stocks to Buy for March
March 08, 2025
These 5 stocks look rather intriguing at current levels.
Via
The Motley Fool
In a market where value is scarce, MERCK & CO. INC. (NYSE:MRK) offers a refreshing opportunity with its solid fundamentals.
March 08, 2025
Discover MERCK & CO. INC., an undervalued stock. NYSE:MRK showcases solid financial health and profitability while maintaining an appealing valuation.
Via
Chartmill
ImmunityBio Analyst Predicts Strong 2025 For New Bladder Cancer Drug
March 06, 2025
HC Wainwright initiates coverage on ImmunityBio with a Buy rating, citing Anktiva's growth potential. The firm projects $4.3 billion in sales, up from $137M in 2025.
Via
Benzinga
Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers
March 04, 2025
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Bristol-Myers Squibb (NYSE:BMY) and the best...
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
Pfizer CEO Says Company May Shift Overseas Manufacturing To US Amid Looming Tariff Threats: 'Will The Trump Administration Co-Invest', Asks Analyst
March 04, 2025
In light of potential tariff threats from President Donald Trump, Pfizer Inc.'s (PFE.N) CEO Albert Bourla has suggested the possibility of shifting the company's overseas manufacturing to its U.S....
Via
Benzinga
Topics
Government
World Trade
These S&P 500 Stocks Have Low P/E Ratios — Time to Buy?
March 03, 2025
This article covers three stocks included in the S&P 500 which are showing exceptionally low P/E ratios of 20 or less, indicating potential buys.
Via
MarketBeat
Topics
Stocks
These Vanguard ETFs Show Where the Smart Money Is Moving Now
March 03, 2025
Via
The Motley Fool
Topics
ETFs
4 Sectors That Thrive When Inflation Runs Hot
February 28, 2025
Sticky inflation and higher-for-longer interest rates is causing a rotation out of technology stocks, here are four sectors for investors hunting for value
Via
MarketBeat
Topics
Economy
World Trade
NovoCure Q4 EPS Misses, Revenue Matches
February 27, 2025
NovoCure reported a solid jump in revenue, but earnings fell short due to rising costs and adoption challenges.
Via
The Motley Fool
3 Magnificent S&P 500 Dividend Stocks Down 36% to 64% to Buy and Hold Forever
February 24, 2025
The majority of the market isn't seeing the bigger picture for these stocks and their underlying companies. Big mistake.
Via
The Motley Fool
Topics
Stocks
Wall Street Thinks This Weight-Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk
February 24, 2025
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
87
88
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.